24442316|t|Cultured mycelium Cordyceps sinensis protects liver sinusoidal endothelial cells in acute liver injured mice.
24442316|a|Cultured mycelium Cordyceps sinensis (CMCS) was widely used for a variety of diseases including liver injury, the current study aims to investigate the protective effects of CMCS on liver sinusoidal endothelial cells (LSECs) in acute injury liver and related action mechanisms. The mice were injected intraperitoneally with lipopolysaccharide (LPS) and D-galactosamine (D-GalN). 39 male BABL/c mice were randomly divided into four groups: normal control, model control, CMCS treatment and 1,10-phenanthroline treatment groups. The Serum liver function parameters including alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels were assayed with the commercial kit. The inflammation and scaffold structure in liver were stained with hematoxylin and eosin and silver staining respectively. The LSECs and sub-endothelial basement membrane were observed with the scanning and transmission electronic microscope. The protein expressions of intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) in liver were analyzed with Western blotting. Expression of von Willebrand factor (vWF) was investigated with immunofluorescence staining. The lipid peroxidation indicators including antisuperoxideanion (ASAFR), hydroxyl free radical (.OH), superoxide dismutase (SOD), malondialdehyde and glutathione S-transferase (GST) were determined with kits, and matrix metalloproteinase-2 and 9 (MMP-2/9) activities in liver were analyzed with gelatin zymography and in situ fluorescent zymography respectively. The model mice had much higher serum levels of ALT and AST than the normal mice. Compared to that in the normal control, more severe liver inflammation and hepatocyte apoptosis, worse hepatic lipid peroxidation demonstrated by the increased ASAFR, .OH and MDA, but decreased SOD and GST, increased MMP-2/9 activities and VCAM-1, ICAM-1 and vWF expressions, which revealed obvious LSEC injury and scaffold structure broken, were shown in the model control. Compared with the model group, CMCS and 1,10-phenanthroline significantly improved serum ALT/AST, attenuated hepatic inflammation and improved peroxidative injury in liver, decreased MMP-2/9 activities in liver tissue, improved integration of scaffold structure, and decreased protein expression of VCAM-1 and ICAM-1. CMCS could protect LSECs from injury and maintain the microvasculature integration in acute injured liver of mice induced by LPS/D-GalN. Its action mechanism was associated with the down-regulation of MMP-2/9 activities and inhibition of peroxidation in injured liver.
24442316	0	36	Cultured mycelium Cordyceps sinensis	ChemicalEntity	-
24442316	90	103	liver injured	DiseaseOrPhenotypicFeature	D008107
24442316	104	108	mice	OrganismTaxon	10090
24442316	110	146	Cultured mycelium Cordyceps sinensis	ChemicalEntity	-
24442316	148	152	CMCS	ChemicalEntity	-
24442316	206	218	liver injury	DiseaseOrPhenotypicFeature	D008107
24442316	284	288	CMCS	ChemicalEntity	-
24442316	344	356	injury liver	DiseaseOrPhenotypicFeature	D008107
24442316	392	396	mice	OrganismTaxon	10090
24442316	434	452	lipopolysaccharide	ChemicalEntity	D008070
24442316	454	457	LPS	ChemicalEntity	D008070
24442316	463	478	D-galactosamine	ChemicalEntity	D005688
24442316	480	486	D-GalN	ChemicalEntity	D005688
24442316	497	503	BABL/c	CellLine	CVCL_0184
24442316	504	508	mice	OrganismTaxon	10090
24442316	580	584	CMCS	ChemicalEntity	-
24442316	599	618	1,10-phenanthroline	ChemicalEntity	C025205
24442316	683	707	alanine aminotransferase	GeneOrGeneProduct	76282
24442316	709	712	ALT	GeneOrGeneProduct	76282
24442316	718	744	aspartate aminotransferase	GeneOrGeneProduct	14718
24442316	746	749	AST	GeneOrGeneProduct	14718
24442316	800	812	inflammation	DiseaseOrPhenotypicFeature	D007249
24442316	1066	1099	intercellular adhesion molecule-1	GeneOrGeneProduct	15894
24442316	1101	1107	ICAM-1	GeneOrGeneProduct	15894
24442316	1113	1146	vascular cell adhesion molecule-1	GeneOrGeneProduct	22329
24442316	1148	1154	VCAM-1	GeneOrGeneProduct	22329
24442316	1216	1237	von Willebrand factor	GeneOrGeneProduct	22371
24442316	1239	1242	vWF	GeneOrGeneProduct	22371
24442316	1299	1304	lipid	ChemicalEntity	D008055
24442316	1368	1389	hydroxyl free radical	ChemicalEntity	D017665
24442316	1391	1394	.OH	ChemicalEntity	D017665
24442316	1397	1417	superoxide dismutase	GeneOrGeneProduct	20655
24442316	1419	1422	SOD	GeneOrGeneProduct	20655
24442316	1425	1440	malondialdehyde	ChemicalEntity	D008315
24442316	1445	1470	glutathione S-transferase	GeneOrGeneProduct	54486
24442316	1472	1475	GST	GeneOrGeneProduct	14870
24442316	1508	1540	matrix metalloproteinase-2 and 9	GeneOrGeneProduct	17390,17395
24442316	1542	1549	MMP-2/9	GeneOrGeneProduct	17390,17395
24442316	1668	1672	mice	OrganismTaxon	10090
24442316	1705	1708	ALT	GeneOrGeneProduct	76282
24442316	1713	1716	AST	GeneOrGeneProduct	14718
24442316	1733	1737	mice	OrganismTaxon	10090
24442316	1791	1809	liver inflammation	DiseaseOrPhenotypicFeature	D008107
24442316	1850	1855	lipid	ChemicalEntity	D008055
24442316	1906	1909	.OH	ChemicalEntity	D017665
24442316	1914	1917	MDA	ChemicalEntity	D008315
24442316	1933	1936	SOD	GeneOrGeneProduct	20655
24442316	1941	1944	GST	GeneOrGeneProduct	54486
24442316	1956	1963	MMP-2/9	GeneOrGeneProduct	17390,17395
24442316	1979	1985	VCAM-1	GeneOrGeneProduct	22329
24442316	1987	1993	ICAM-1	GeneOrGeneProduct	15894
24442316	1998	2001	vWF	GeneOrGeneProduct	22371
24442316	2038	2049	LSEC injury	DiseaseOrPhenotypicFeature	D008107
24442316	2145	2149	CMCS	ChemicalEntity	-
24442316	2154	2173	1,10-phenanthroline	ChemicalEntity	C025205
24442316	2203	2206	ALT	GeneOrGeneProduct	76282
24442316	2207	2210	AST	GeneOrGeneProduct	14718
24442316	2223	2243	hepatic inflammation	DiseaseOrPhenotypicFeature	D008107
24442316	2270	2285	injury in liver	DiseaseOrPhenotypicFeature	D008107
24442316	2297	2304	MMP-2/9	GeneOrGeneProduct	17390,17395
24442316	2413	2419	VCAM-1	GeneOrGeneProduct	22329
24442316	2424	2430	ICAM-1	GeneOrGeneProduct	15894
24442316	2432	2436	CMCS	ChemicalEntity	-
24442316	2451	2468	LSECs from injury	DiseaseOrPhenotypicFeature	D008107
24442316	2524	2537	injured liver	DiseaseOrPhenotypicFeature	D008107
24442316	2541	2545	mice	OrganismTaxon	10090
24442316	2557	2560	LPS	ChemicalEntity	D008070
24442316	2561	2567	D-GalN	ChemicalEntity	D005688
24442316	2633	2640	MMP-2/9	GeneOrGeneProduct	17390,17395
24442316	2686	2699	injured liver	DiseaseOrPhenotypicFeature	D008107
24442316	Association	14718	D008107	Novel
24442316	Association	76282	D008107	Novel
24442316	Positive_Correlation	C025205	14718	Novel
24442316	Positive_Correlation	C025205	76282	Novel
24442316	Negative_Correlation	C025205	15894	Novel
24442316	Negative_Correlation	C025205	22329	Novel
24442316	Negative_Correlation	C025205	17395	Novel
24442316	Negative_Correlation	C025205	17390	Novel
24442316	Negative_Correlation	C025205	D008107	Novel
24442316	Positive_Correlation	D008107	D008070	No
24442316	Positive_Correlation	D008107	D008315	Novel
24442316	Positive_Correlation	D008107	D017665	Novel
24442316	Association	D008107	22371	Novel
24442316	Association	D008107	15894	Novel
24442316	Association	D008107	22329	Novel
24442316	Association	D008107	17395	Novel
24442316	Association	D008107	17390	Novel
24442316	Association	D008107	54486	Novel
24442316	Association	D008107	20655	Novel
24442316	Association	D008107	D008055	Novel
24442316	Positive_Correlation	D005688	D008107	No